The efficacy of oscillatory positive expiratory pressure device (Aerobika).
Not Applicable
- Conditions
- Chronic Obstructive Pulmonary Disease
- Registration Number
- JPRN-UMIN000032655
- Lead Sponsor
- Division of Respiratory Medicine, Department of Internal Medicine, St. Marianna University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
The condition that the investigator judges to exclude from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in FEV1 before and after 4-week treatment with Aerobika.
- Secondary Outcome Measures
Name Time Method Following parameters will be assessed for before and at 4-week 4-week treatment with Aerobika. 1. VC, FVC, V50, and V25 2. IOS(R5, R5ins, R5exp, R20, X5, X5ins, X5exp, Fres, Ax) 3. 6 minute-walking test 4. CAT score, mMRC 5. Acute exacerbation